New incarnation of the life sciences IPO: Bain’s Cerevel

The SPAC route allows Cerevel to combine two transactions into a single event, all the while presenting a more educated investor base pre-IPO, a senior executive on Bain's life sciences team said.

DealsNorth AmericaUSHealthcareFeaturedTop Stories